These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 29773172)
21. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy. Yang Y; Lu X; Liu Q; Dai Y; Zhu X; Wen Y; Xu J; Lu Y; Zhao D; Chen X; Li N Eur J Pharm Sci; 2017 Jul; 105():219-229. PubMed ID: 28526602 [TBL] [Abstract][Full Text] [Related]
22. 6,6″-Dimethyl-2,2':6',2″-terpyridine revisited: new fluorescent silver(I) helicates with in vitro antiproliferative activity via selective nucleoli targeting. Fik MA; Gorczyński A; Kubicki M; Hnatejko Z; Fedoruk-Wyszomirska A; Wyszko E; Giel-Pietraszuk M; Patroniak V Eur J Med Chem; 2014 Oct; 86():456-68. PubMed ID: 25200981 [TBL] [Abstract][Full Text] [Related]
23. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity. Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289 [TBL] [Abstract][Full Text] [Related]
24. A drug-loaded nanoscale metal-organic framework with a tumor targeting agent for highly effective hepatoma therapy. Li YA; Zhao XD; Yin HP; Chen GJ; Yang S; Dong YB Chem Commun (Camb); 2016 Dec; 52(98):14113-14116. PubMed ID: 27858003 [TBL] [Abstract][Full Text] [Related]
25. Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II). Kovala-Demertzi D; Hadjipavlou-Litina D; Staninska M; Primikiri A; Kotoglou C; Demertzis MA J Enzyme Inhib Med Chem; 2009 Jun; 24(3):742-52. PubMed ID: 18720191 [TBL] [Abstract][Full Text] [Related]
26. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity. Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018 [TBL] [Abstract][Full Text] [Related]
27. Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance. Johansson K; Ito M; Schophuizen CM; Mathew Thengumtharayil S; Heuser VD; Zhang J; Shimoji M; Vahter M; Ang WH; Dyson PJ; Shibata A; Shuto S; Ito Y; Abe H; Morgenstern R Mol Pharm; 2011 Oct; 8(5):1698-708. PubMed ID: 21851097 [TBL] [Abstract][Full Text] [Related]
28. Combination efficacy of doxorubicin and adenoviral methioninase gene therapy with prodrug selenomethionine. Gupta A; Miki K; Xu M; Yamamoto N; Moossa AR; Hoffman RM Anticancer Res; 2003; 23(2B):1181-8. PubMed ID: 12820369 [TBL] [Abstract][Full Text] [Related]
29. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells. Miao J; Du YZ; Yuan H; Zhang XG; Hu FQ Colloids Surf B Biointerfaces; 2013 Oct; 110():74-80. PubMed ID: 23711779 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes. Putta VR; Chintakuntla N; Mallepally RR; Avudoddi S; K N; Nancherla D; V V N Y; R S P; Surya SS; Sirasani S J Fluoresc; 2016 Jan; 26(1):225-40. PubMed ID: 26555289 [TBL] [Abstract][Full Text] [Related]
32. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study. Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748 [TBL] [Abstract][Full Text] [Related]
33. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli. Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655 [TBL] [Abstract][Full Text] [Related]
34. Doxorubicin-loaded polypeptide nanorods based on electrostatic interactions for cancer therapy. Zhang L; Zhang P; Zhao Q; Zhang Y; Cao L; Luan Y J Colloid Interface Sci; 2016 Feb; 464():126-36. PubMed ID: 26609932 [TBL] [Abstract][Full Text] [Related]
35. Tumor delivery of liposomal doxorubicin prepared with poly-L-glutamic acid as a drug-trapping agent. Miatmoko A; Kawano K; Yoda H; Yonemochi E; Hattori Y J Liposome Res; 2017 Jun; 27(2):99-107. PubMed ID: 26982164 [TBL] [Abstract][Full Text] [Related]
36. Synthesis, characterization, DNA interactions, DNA cleavage, radical scavenging activity, antibacterial, anti-proliferative and docking studies of new transition metal complexes. Chennam KP; Ravi M; Ushaiah B; Srinu V; Eslavath RK; Devi ChS J Fluoresc; 2016 Jan; 26(1):189-205. PubMed ID: 26545354 [TBL] [Abstract][Full Text] [Related]
37. Syntheses, characterization, antimicrobial and cytotoxic activities of pyridine-2,5-dicarboxylate complexes with 1,10-phenanthroline. Colak AT; Oztopcu-Vatan P; Colak F; Akduman D; Kabadere S; Uyar R J Trace Elem Med Biol; 2013 Oct; 27(4):295-301. PubMed ID: 23669312 [TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory, antiproliferative, and radical-scavenging activities of tolfenamic acid and its metal complexes. Kovala-Demertzi D; Hadjipavlou-Litina D; Primikiri A; Staninska M; Kotoglou C; Demertzis MA Chem Biodivers; 2009 Jun; 6(6):948-60. PubMed ID: 19551737 [TBL] [Abstract][Full Text] [Related]